vaayaa Inclusive Education
Healthcare 1 min read

FDA Approves First New Molecular Entity Under National Priority Voucher Program

Apr 23, 2026

The U.S. Food and Drug Administration today approved Foundayo (orforglipron) marking the fifth approval under the Commissioner's National Priority Voucher (CNPV) pilot program.

Read full article on FDA Press Releases →

Source: FDA Press Releases — US Government, Public Domain

More in Healthcare

Can Ozempic prevent cancer? A doctor explains why the headlines are easy to misread The Conversation Health · 2 min Autistic children drown at alarming rates - swim lessons and water safety strategies can save their lives The Conversation Health · 2 min FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturing FDA Press Releases · 1 min FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol FDA Press Releases · 1 min